1. MO-0649 Feasibility of MR-guided stereotactic ablative body radiotherapy of lymph node oligometastases. (May 2022) Authors: Batumalai, V.; Crawford, D.; Pagulayan, C.; Hogan, L.; Jelen, U.; Loo, C.; Dunkerley, N.; Picton, M.; Geddes, L.; Alvares, S.; Sampaio, S.; Heinke, M.; Twentyman, T.; Jameson, M.; de Leon, J. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S584 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PD-0325 Feasibility and safety of MR-guided stereotactic ablative body radiotherapy for Prostate Cancer. (May 2022) Authors: Geddes, L.; Crawford, D.; Batumalai, V.; Pagulayan, C.; Hogan, L.; Jelen, U.; Loo, C.; Dunkerley, N.; Picton, M.; Alvares, S.; Sampaio, S.; Heinke, M.; Twentyman, T.; Jameson, M.; De Leon, J. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PD-0334 Feasibility of magnetic resonance-guided stereotactic ablative body radiotherapy of liver cancer. (May 2022) Authors: Picton, M.; Batumalai, V.; Crawford, D.; Pagulayan, C.; Hogan, L.; Jelen, U.; Loo, C.; Dunkerley, N.; Geddes, L.; Sampaio, S.; Heinke, M.; Twentyman, T.; Jameson, M.; de Leon, J. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-1037 Patterns of care and acute toxicity of MR-Linac: Initial results from the first 1000 fractions. (May 2022) Authors: Batumalai, V.; Jameson, M.; Crawford, D.; Hogan, L.; Loo, C.; Picton, M.; Geddes, L.; Alvares, S.; Lynch, J.; Woods, A.; Rosario, R.; Pagulayan, C.; Jelen, U.; Dunkerley, N.; Sampaio, S.; Heinke, M.; Twentyman, T.; de Leon, J. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S872 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-1374 Feasibility of magnetic resonance-guided adaptive post-prostatectomy radiotherapy. (May 2022) Authors: Hassan, S.; Jameson, M.; Batumalai, V.; Crawford, D.; Moutrie, Z.; Hogan, L.; Loo, C.; Picton, M.; Pagulayan, C.; Jelen, U.; Alvares, S.; Heinke, M.; Sampaio, S.; Simon, K.; Twentyman, T.; Dwivedi, N.; de Leon, J. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-1558 MR Linac Stereotactic Prostate:Accumulated dose comparison of adaptive versus non adaptive treatment. (August 2021) Authors: de Leon, J.; Crawford, D.; Hogan, L.; Moutrie, Z.; Pagulayan, C.; Loo, C.; Heinke, M.; Sampaio, S.; Alvares, S.; Johnson, A.; Simon, K.; Twentyman, T.; Jameson, M. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PO-1602 Dosimetric impact of liquid Helium top-up for a 1.5 T MR Linac. (August 2021) Authors: Jameson, M.; Jelen, U.; Moutrie, Z.; Pagulayan, C.; Dunkerly, N. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗